ABT-737 and its derivatives (ABT-263 and ABT199) inhibit the interaction between Beclin-1 and Bcl2 to induce autophagic-like cell death, which has anticancer effects on glioblastoma cells (366). The gene discussed is BECN1; the disease is glioblastoma.